Amid new findings on today’s C-suite approach to digital transformation, experts explore the intersection of data and technology and the areas that must evolve to meet the digital health demands of tomorrow.
... /Read more/
Jennifer Buell, COO at Agenus, discusses the need for additional immunotherapies and combination strategies in cancer—building on learnings from the first wave of immune checkpoint inhibitors.
... /Read more/
A look at how medical affairs is transitioning to a new, fundamental strategic role within pharma and ways it can step up to own this role, particularly within emerging markets.
... /Read more/
A new drug shortages report from FDA revives the call for a rating system to help drug purchasers, hospital buying groups and consumers identify quality products that warrant higher prices. Jill Wechsler reports.
... /Read more/
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
... /Read more/
